WH Gerlich - Medical microbiology and immunology, 2015 - Springer
Large-scale vaccination against hepatitis B virus (HBV) infection started in 1984 with first- generation vaccines made from plasma of chronic carriers containing HBV surface antigen …
J Choi, JO Kim - Journal of Microbiology, 2022 - Springer
Abstract Middle East Respiratory Syndrome coronavirus (MERS-CoV), a contagious zoonotic virus, causes severe respiratory infection with a case fatality rate of approximately …
A sizeable proportion (1–10%) of healthy adults and to lesser extent neonates vaccinated with triple 10μg hepatitis B (HB) vaccine fail to mount a protective antibody response …
HJ Yang, M Chen, T Cheng, SZ He, SW Li… - World Journal of …, 2005 - ncbi.nlm.nih.gov
AIM: To improve the immunogenicity of receptor binding site of hepatitis B virus (HBV) on preS1 antigen using HBV core antigen as an immuno-carrier. METHODS: One to 6 tandem …
P Ungulkraiwit, Y Jongjirawisan… - … Asian journal of …, 2007 - tm.mahidol.ac.th
This study aimed to determine the predicting factors for successful hepatitis B vaccination among HIV-1 infected patients. A prospective study was conducted among HIV-1 infected …
To assess persistence of anti-HBs and immunologic memory of non-responders after revaccination, 40 healthy non-responder children were given a three-dose recombinant …
JH Park, MK Lee, HS Kim, KL Kim… - Journal of Viral …, 2003 - Wiley Online Library
The 55‐amino acid (aa) preS2 region of the hepatitis B virus (HBV) envelope protein is highly immunogenic, and antibodies against this epitope confer seroprotection against HBV …